Imaging of spinal metastases: modality performance, complications, and differential diagnosis
Neurochirurgie · 2026
DOI: 10.1016/j.neuchi.2026.101804 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochirurgie, 2026. Verfasst von Quentin Beaufort und 2 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic and Interventional Neuroradiology, Tours University Hospital, Tours, France; Centre d'Investigation Clinique - Innovation Technologique (C…. Hauptthemen laut MEDLINE: Spinal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Spinal metastases are the most common malignant involvement of the axial skeleton and a major source of cancer-related morbidity. Imaging is central throughout patient management, from initial detection and differential diagnosis of vertebral lesions to staging, treatment planning, and early identification of complications. Magnetic resonance imaging (MRI) is the reference modality owing to its high sensitivity for marrow infiltration and its ability to assess epidural extension and spinal cord compression in a single examination. Computed tomography (CT) remains essential for evaluating cortical destruction and mechanical instability, particularly within the Spinal Instability Neoplastic Score (SINS) framework, although it is less sensitive for early marrow disease. Nuclear medicine and positron emission tomography (PET) techniques provide complementary whole-body assessment, with performance depending on tumour biology. While bone scintigraphy has variable specificity, SPECT improves lesion localisation. 18F-FDG PET/CT sensitivity varies according to tumour phenotype, whereas 18F-NaF PET/CT demonstrates high sensitivity for osteoblastic metastases. In prostate cancer, PSMA PET/CT offers excellent staging accuracy. Complications, including pathological vertebral compression fractures and metastatic epidural spinal cord compression, are oncologic emergencies requiring prompt imaging. Current guidelines recommend urgent MRI, ideally within 24 h. Neural compromise is graded using the Bilsky ESCC scale, and instability is assessed with SINS. Emerging MRI-based morphometric parameters remain investigational. Differential diagnosis relies primarily on T1 marrow signal assessment, integrated with CT features and advanced MRI techniques. Optimal imaging strategies require integrating modality performance with tumour biology and clinical context to guide multidisciplinary decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diagnostic and Interventional Neuroradiology, Tours University Hospital, Tours, France; Centre d'Investigation Clinique - Innovation Technologique (CIC-IT) 1415, Tours University Hospital Tours, France; Université de To…
- Diagnostic and Interventional Neuroradiology, Tours University Hospital, Tours, France.
- Médecine Nucléaire Tourangelle 37 (MNT 37), Tours, France.
Zitieren
APA
Beaufort, Q., Lefevre, V., & Carsuzaa, T. (2026). Imaging of spinal metastases: modality performance, complications, and differential diagnosis. Neurochirurgie. https://doi.org/10.1016/j.neuchi.2026.101804
Vancouver
Beaufort Q, Lefevre V, Carsuzaa T. Imaging of spinal metastases: modality performance, complications, and differential diagnosis. Neurochirurgie. 2026. doi:10.1016/j.neuchi.2026.101804
BibTeX
@article{Beaufort2026,
author = {Beaufort, Quentin and Lefevre, Valentin and Carsuzaa, Thibault},
title = {Imaging of spinal metastases: modality performance, complications, and differential diagnosis},
journal = {Neurochirurgie},
year = {2026},
doi = {10.1016/j.neuchi.2026.101804}
}
EUVIMED